...the fact that Teva has agreed to a drawn-out timeline in which a trial could not start until 2013 suggests that Teva has no expectation of getting FDA approval in the next two years...
Excuse my denseness, but I read the entire document you linked to and I can't figure out how you arrive at the conclusion that TEVA doesn't expect FDA approval in the next two years. Can you explain your rationale?
Unless I'm totally misunderstanding things, (which, when legal matters are involved is more than possible) TEVA has managed to kick the can more than a year down the road - which I count as a win for TEVA - and I imagine they will portray it as such.
Heck, why wouldn't TEVA celebrate? A guarantee of no trial for 1+ years equates to no expectation of t-enox approval on TEVA's part?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.